Exhibitors Search
IMITAR SCIENCE
Booth no.
A24
| Exhibition | NextRegenX |
|---|---|
| Country | Korea, South |
| Address | 85 Songdogwahak-ro, Yeonsu-gu, Incheon, Republic of Korea |
| Tel (Rep.) | 010-4616-9155 |
| Website | http://imitarscience.com/ |
Company Introduction
IMITAR Science Co., Ltd. provides efficacy, pharmacological, and toxicity evaluation of active compounds, as well as drug development screening platforms, based on biomimetic multi-organ chip technology. Furthermore, we aim to revolutionarily replace the preclinical stage of animal testing.
The ultimate goal of IMITAR Science is to grow into a non-clinical CRO company that performs outsourced toxicity and pharmacological evaluations using biomimetic organ-on-a-chip systems that replicate human organs.
We strive to contribute to drug development and precision medicine, laying the foundation for a leading bio-health nation. Through continuous development of better products, we aim to achieve customer satisfaction and create value that enriches our lives and society. We are committed to always giving our best to become such a company.
The ultimate goal of IMITAR Science is to grow into a non-clinical CRO company that performs outsourced toxicity and pharmacological evaluations using biomimetic organ-on-a-chip systems that replicate human organs.
We strive to contribute to drug development and precision medicine, laying the foundation for a leading bio-health nation. Through continuous development of better products, we aim to achieve customer satisfaction and create value that enriches our lives and society. We are committed to always giving our best to become such a company.
Promotional video
Exhibit Item
Multi-Organ Organ-on-a-Chip
Exhibit Item Images
Exhibit Description
A system that interconnects heterogeneous organoids through micro-channels to construct a human-like metabolic system, applying fluid dynamics to simulate pharmacological metabolism.
Co-Exhibitor or
Partner’s Information
| Company Name | Country |
|---|---|
KYUNGYON EXHIBITION CORP.